Consequently, NAC has become increasingly popular in operable BC, when initial breast conservation is deemed to be not feasible, but also in smaller tumors, notably in subtypes in which adjuvant chemotherapy is almost always necessary and the probability of response is the highest, such as HER2‐positive and triple‐negative BC (TNBC). Here, ERBB2 is linked to breast cancer.